Cover Image
市場調查報告書

血管注射部位閉塞設備的全球市場

International Markets for Vascular Access Site Closure Devices

出版商 Medtech Insight 商品編碼 309480
出版日期 內容資訊 英文 179 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
血管注射部位閉塞設備的全球市場 International Markets for Vascular Access Site Closure Devices
出版日期: 2014年07月01日 內容資訊: 英文 179 Pages
簡介

美國每34秒就有1人經歷冠狀動脈事件,每83秒就有1人因此致死。現在,美國20歲以上的成人有1,540萬人患冠狀動脈心臟病,850萬人患週邊動脈疾病。老年人市場區隔的冠狀動脈、末稍血管疾病的患者數,及心臟疾病、糖尿病及肥胖慢性疾病的患者數,預計今後也將增加。2013年中,全球心血管、末稍血管疾病用注射部位管理設備市場的收益為約9億2,370萬美金。該收益預計2018年達12億美元。

本報告提供全球血管注射部位管理設備市場相關調查、產品、現在、新興市場、競爭企業及供應商的機會等分析、各地區、主要國家的市場預測等彙整資料,為您概述為以下內容。

摘要整理

第1章 心血管疾病概要

  • 心臟、循環系
  • 主要的心臟疾病/障礙
    • 冠狀動脈心臟病
    • 高血壓
    • 心肌病
    • 先天性心臟缺陷
    • 心臟衰竭
  • 末稍血管疾病概要
  • 循環繫結構、生理功能
  • 末稍血管疾病的種類
    • 週邊動脈疾病
    • 動脈瘤
    • 深部靜脈血栓症、肺動脈栓塞
    • 慢性靜脈不全

第2章 血管注射部位閉塞設備

  • 技術
  • 併發症
  • 產品

第3章 全球血管注射部位管理設備市場預測

  • 競爭企業
  • 市場預測:北美
    • 競爭企業
    • 市場預測:美國
    • 市場預測:加拿大
  • 市場預測:歐洲
    • 競爭企業
    • 市場預測:法國
    • 市場預測:德國
    • 市場預測:義大利
    • 市場預測:西班牙
    • 市場預測:英國
  • 市場預測:亞太地區
    • 競爭企業
    • 市場預測:中國
    • 市場預測:印度
    • 市場預測:日本
    • 市場預測:韓國
    • 市場預測:台灣
  • 市場預測:非洲、中東
  • 市場預測:中南美
    • 競爭企業
    • 市場預測:巴西
    • 市場預測:阿根廷
    • 市場預測:墨西哥

附錄

目錄
Product Code: A203

Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have coronary and peripheral vascular disease is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in the U.S. suffer from coronary heart disease and 8.5 million adults age 20 or older in the U.S. have peripheral artery disease.

Interventional management of cardiovascular and peripheral vascular diseases via transcatheter techniques requires vascular access site management systems in order to prevent bleeding and the formation of hematoma following introducer/sheath removal. Vascular access site closure devices have evolved beyond simple manual compression devices since their initial introduction in 1995 by Datascope (now part of Maquet Holding). However, manual compression remains the gold standard despite limitations to its use, including the need for the patient to be undergoing anticoagulation therapy or have undergone an endovascular intervention with a large access site. In 2013, vascular access site management devices for cardiovascular and peripheral indications generated approximately $923.7 million internationally in corresponding product sales; it is expected that, in the year 2018, these methods will generate an estimated $1.2 billion in corresponding product sales.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of vascular access site management devices to international markets. Regions covered in this report include North America, Europe, Asia-Pacific, Africa and the Middle East, and Central and South America. Select countries and the vascular access site management systems markets from these regions are analyzed in depth.

Table of Contents

EXECUTIVE SUMMARY

  • i. Global Market Forecast For Vascular Access Site Management Devices
    • a. North America
    • b. Europe
    • c. Asia-Pacific
    • d. Africa and the Middle East
    • e. Central and South America
  • ii. Methodology
  • Exhibit ES-1: Global Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit ES-2: 2013, Global Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit ES-3: 2013, North American Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit ES-4: 2013, European Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit ES-5: 2013, Asia-Pacific Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit ES-6: 2013, African and Middle Eastern Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit ES-7: 2013, Central and South American Vascular Access Site Closure Systems, Share by Supplier

1. CARDIOVASCULAR DISEASE OVERVIEW

  • 1.1 The Heart and Circulatory System
  • 1.2 Selected Heart Diseases/Disorders
    • 1.2.1 Coronary Heart Disease
      • 1.2.1.1 Atherosclerosis
      • 1.2.1.2 Angina Pectoris
      • 1.2.1.3 Myocardial Infarction
    • 1.2.2 Hypertension
      • 1.2.2.1 Systolic and Diastolic Pressures
      • 1.2.2.2 Prehypertension
    • 1.2.3 Cardiomyopathy
      • 1.2.3.1 Dilated Cardiomyopathy
      • 1.2.3.2 Hypertrophic Cardiomyopathy
      • 1.2.3.3 Restrictive Cardiomyopathy
    • 1.2.4 Congenital Heart Defects
      • 1.2.4.1 Ventricular Septal Defects
      • 1.2.4.2 Atrial Septal Defects
      • 1.2.4.3 Patent Ductus Arteriosus
    • 1.2.5 Heart Failure
      • 1.2.5.1 Disease Development
      • 1.2.5.2 Ejection Fraction Reduction
      • 1.2.5.3 Classification/Staging Systems
  • 1.3 Peripheral Vascular Disease Overview
  • 1.4 Anatomy and Physiology of the Circulatory System
  • 1.5 Types of Peripheral Vascular Disease
    • 1.5.1 Peripheral Artery Disease
      • 1.5.1.1 Etiology
      • 1.5.1.2 Epidemiology
    • 1.5.2 Aneurysm
      • 1.5.2.1 Etiology
      • 1.5.2.2 Epidemiology
    • 1.5.3 Deep Vein Thrombosis and Pulmonary Embolism
      • 1.5.3.1 Etiology
      • 1.5.3.2 Epidemiology
    • 1.5.4 Chronic Venous Insufficiency
      • 1.5.4.1 Etiology
      • 1.5.4.2 Epidemiology
  • Exhibit 1-1: Cross-Section Diagram of the Heart
  • Exhibit 1-2: Statistics for Selected Coronary Heart Disease Risk Factors
  • Exhibit 1-3: Standard Angina Pectoris Classification
  • Exhibit 1-4: Angina Pectoris, Selected Statistics
  • Exhibit 1-5: Clinical Classification of AMI
  • Exhibit 1-6: Myocardial Infarction, Selected Statistics
  • Exhibit 1-7: Percentage of Adults Diagnosed With High Blood Pressure, by State
  • Exhibit 1-8: Hypertension, Selected Statistics
  • Exhibit 1-9: Cardiomyopathy, Selected Statistics
  • Exhibit 1-10: Congenital Heart Defects, Selected Statistics
  • Exhibit 1-11: Summary, New York Heart Association Heart Failure Classification System
  • Exhibit 1-12: Summary, American College of Cardiology/American Heart Association Heart Failure Staging System
  • Exhibit 1-13: Heart Failure, Selected Statistics
  • Exhibit 1-14: Peripheral Artery Disease, Selected Statistics
  • Exhibit 1-15: Aortic Aneurysm, Selected Statistics
  • Exhibit 1-16: Deep Vein Thrombosis, Selected Statistics
  • Exhibit 1-17: Classification of Chronic Venous Insuffiency
  • Exhibit 1-18: Chronic Venous Insufficiency, Selected Statistics

2. VASCULAR ACCESS SITE CLOSURE DEVICES

  • 2.1 Technologies
  • 2.2 Complications
  • 2.3 Products
  • Exhibit 2-1: 2014, Selected Vascular Access Site Closure Devices

3. GLOBAL MARKET FORECAST FOR VASCULAR ACCESS SITE MANAGEMENT DEVICES

  • 3.1 Competitors
  • 3.2 Market Forecast: North America
    • 3.2.1 Competitors
    • 3.2.2 Market Forecast By Selected Countries: United States
      • 3.2.2.1 Competitors
    • 3.2.3 Market Forecast By Selected Countries: Canada
      • 3.2.3.1 Competitors
  • 3.3 Market Forecast: Europe
    • 3.3.1 Competitors
    • 3.3.2 Market Forecast By Selected Countries: France
      • 3.3.2.1 Competitors
    • 3.3.3 Market Forecast By Selected Countries: Germany
      • 3.3.3.1 Competitors
    • 3.3.4 Market Forecast By Selected Countries: Italy
      • 3.3.4.1 Competitors
    • 3.3.5 Market Forecast By Selected Countries: Spain
      • 3.3.5.1 Competitors
    • 3.3.6 Market Forecast By Selected Countries: United Kingdom
      • 3.3.6.1 Competitors
  • 3.4 Market Forecast: Asia-Pacific
    • 3.4.1 Competitors
    • 3.4.2 Market Forecast By Selected Countries: China
      • 3.4.2.1 Competitors
    • 3.4.3 Market Forecast By Selected Countries: India
      • 3.4.3.1 Competitors
    • 3.4.4 Market Forecast By Selected Countries: Japan
      • 3.4.4.1 Competitors
    • 3.4.5 Market Forecast By Selected Countries: South Korea
      • 3.4.5.1 Competitors
    • 3.4.6 Market Forecast By Selected Countries: Taiwan
      • 3.4.6.1 Competitors
  • 3.5 Market Forecast: Africa and the Middle East
    • 3.5.1 Competitors
  • 3.6 Market Forecast: Central and South America
    • 3.6.1 Competitors
    • 3.6.2 Market Forecast By Selected Countries: Brazil
      • 3.6.2.1 Competitors
    • 3.6.3 Market Forecast By Selected Countries: Argentina
      • 3.6.3.1 Competitors
    • 3.6.4 Market Forecast By Selected Countries: Mexico
      • 3.6.4.1 Competitors
  • Exhibit 3-1: Global Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-2: 2013, Global Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-3: North American Vascular Access Site Closure Device, Market Forecast, 2013-2018
  • Exhibit 3-4: 2013, North American Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-5: United States Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-6: 2013, United States Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-7: Canadian Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-8: 2013, Canadian Vascular Access Site Closure Systems, Share By Supplier
  • Exhibit 3-9: European Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-10: Vascular Access Site Closure System Sales For Select European Countries, Combined Market Forecast, 2013-2018
  • Exhibit 3-11: 2013, European Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-12: 2013, French Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-13: 2013, German Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-14: 2013, Italian Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-15: 2013, Spanish Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-16: 2013, United Kingdom Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-17: Asia-Pacific Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-18: Vascular Access Site Closure System Sales For Select Asia-Pacific Countries ,Combined Market Forecast, 2013-2018
  • Exhibit 3-19: 2013, Asia-Pacific Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-20: 2013, Chinese Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-21: 2013, Indian Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-22: 2013, Japanese Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-23: 2013, South Korean Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-24: 2013, Taiwanese Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-25: African and Middle Eastern Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-26: 2013, African and Middle Eastern Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-27: Central and South America Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-28: Vascular Access Site Closure System Sales For Select Central and South American Countries, Combined Market Forecast, 2013-2018
  • Exhibit 3-29: 2013, Central and South American Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-30: 2013, Brazilian Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-31: 2013, Argentinean Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-32: 2013, Mexican Vascular Access Site Closure Systems, Share by Supplier

APPENDIX: COMPANY LISTING

Back to Top